BioMarin
BioMarin Pharmaceutical Inc., headquartered in the United States, is a leading biotechnology company specialising in innovative therapies for rare genetic diseases. Founded in 1997, BioMarin has established itself as a pioneer in the industry, focusing on the development of enzyme replacement therapies and gene therapies that address unmet medical needs. With a strong presence in North America, Europe, and Asia, BioMarin's core products include treatments for conditions such as phenylketonuria (PKU) and mucopolysaccharidosis (MPS). The company is renowned for its commitment to research and development, which has led to several groundbreaking therapies that significantly improve patient outcomes. BioMarin's dedication to rare disease treatment has positioned it as a market leader, earning recognition for its innovative approach and impactful contributions to the biotechnology sector.
DitchCarbon Score
How does BioMarin's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
BioMarin's score of 13 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
BioMarin's reported carbon emissions
BioMarin, headquartered in the US, currently does not provide specific carbon emissions data or reduction targets. Without available figures, it is unclear what their current emissions levels are or the scope of their emissions (Scope 1, 2, or 3). However, the company is likely engaged in industry-standard climate commitments, focusing on sustainability and reducing environmental impact. As the biopharmaceutical sector increasingly prioritises climate action, BioMarin may be exploring initiatives to align with broader industry goals, although specific details on their commitments or targets are not disclosed.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
BioMarin is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
